Patient income and health innovation

This study analyzes the relationship between the number of clinical trials in a disease area, the health losses from that disease, and the average income of people suffering from it. Average patient income appears strongly predictive of the number of clinical trials, whether funded by industry or no...

Full description

Saved in:
Bibliographic Details
Published in:Health economics 2020-12, Vol.29 (12), p.1795-1803
Main Authors: Moradpour, Javad, Hollis, Aidan
Format: Article
Language:English
Subjects:
Averages
Clinical research
Clinical trials
Health economics
income inequality
innovation
Innovations
Suffering
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study analyzes the relationship between the number of clinical trials in a disease area, the health losses from that disease, and the average income of people suffering from it. Average patient income appears strongly predictive of the number of clinical trials, whether funded by industry or not. We are able to precisely estimate the relationship between income and the number of trials and to identify both (a) the specific diseases that appear to be underfunded relative to their harm to human health and (b) the amount of additional funding required to bring innovation investment up to the present average.
ISSN:1057-9230
1099-1050
DOI:10.1002/hec.4160